Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Capital Expenditures (2016 - 2025)

Alkermes (ALKS) has disclosed Capital Expenditures for 16 consecutive years, with -$20000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 100.2% to -$20000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $40.4 million, a 20.71% increase, with the full-year FY2025 number at $40.4 million, up 20.71% from a year prior.
  • Capital Expenditures was -$20000.0 for Q4 2025 at Alkermes, down from $17.3 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $17.3 million in Q3 2025 to a low of -$20000.0 in Q4 2025.
  • A 5-year average of $9.4 million and a median of $9.2 million in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 117.62% in 2022, then tumbled 100.2% in 2025.
  • Alkermes' Capital Expenditures stood at $8.7 million in 2021, then rose by 15.78% to $10.0 million in 2022, then surged by 69.82% to $17.0 million in 2023, then crashed by 42.61% to $9.8 million in 2024, then tumbled by 100.2% to -$20000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Capital Expenditures are -$20000.0 (Q4 2025), $17.3 million (Q3 2025), and $13.0 million (Q2 2025).